WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 14.648 ↑ 0.69%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 4.58% 0.69% 1.28% 0.67% 3.07% 10.42%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
89.10% 4.78% (Arbitrage: 0.00%) 0.00% 0.00% 6.12%

Equity

NameSectorWeight %
JB Chemicals & Pharmaceuticals LimitedPharmaceuticals & Biotechnology6.94%
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology6.81%
Fortis Healthcare LimitedHealthcare Services6.69%
Cipla LimitedPharmaceuticals & Biotechnology4.56%
Laurus Labs LimitedPharmaceuticals & Biotechnology4.28%
Krishna Institute Of Medical Sciences LimitedHealthcare Services4.09%
Neuland Laboratories LimitedPharmaceuticals & Biotechnology3.20%
Max Healthcare Institute LimitedHealthcare Services3.19%
Lupin LimitedPharmaceuticals & Biotechnology3.14%
Apollo Hospitals Enterprise LimitedHealthcare Services3.05%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology2.89%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology2.77%
Vijaya Diagnostic Centre LimitedHealthcare Services2.48%
Abbott India LimitedPharmaceuticals & Biotechnology2.14%
Gland Pharma LimitedPharmaceuticals & Biotechnology1.94%
Shaily Engineering Plastics LimitedIndustrial Products1.91%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology1.75%
Jupiter Life Line Hospitals LimitedHealthcare Services1.66%
Kovai Medical Center and Hospital LimitedHealthcare Services1.65%
Mankind Pharma LimitedPharmaceuticals & Biotechnology1.64%
Glenmark Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.61%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.58%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology1.51%
Pfizer LimitedPharmaceuticals & Biotechnology1.50%
AstraZeneca Pharma India LimitedPharmaceuticals & Biotechnology1.48%
Alembic Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.40%
Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.36%
Eris Lifesciences LimitedPharmaceuticals & Biotechnology1.19%
Thyrocare Technologies LimitedHealthcare Services1.19%
Poly Medicure LimitedHealthcare Equipment & Supplies1.03%
Acutaas Chemicals LimitedPharmaceuticals & Biotechnology0.94%
Healthcare Global Enterprises LimitedHealthcare Services0.80%
Dr.Agarwals Eye Hospital LimitedHealthcare Services0.79%
Supriya Lifescience LimitedPharmaceuticals & Biotechnology0.79%
Navin Fluorine International LimitedChemicals & Petrochemicals0.75%
Shilpa Medicare LimitedPharmaceuticals & Biotechnology0.70%
Aster DM Healthcare LimitedHealthcare Services0.58%
Zota Health Care LimitedPharmaceuticals & Biotechnology0.56%
Piramal Pharma LimitedPharmaceuticals & Biotechnology0.51%
PB Fintech LimitedFinancial Technology (Fintech)0.50%
Jubilant Ingrevia LimitedChemicals & Petrochemicals0.46%
Orchid Pharma LimitedPharmaceuticals & Biotechnology0.45%
Onesource Specialty Pharma LimitedPharmaceuticals & Biotechnology0.42%
Laxmi Dental LimitedHealthcare Equipment & Supplies0.22%

Debt

NameRatingWeight %
91 Days Tbill (MD 02/10/2025)Sovereign1.13%
364 Days Tbill (MD 18/12/2025)Sovereign1.12%
182 Days Tbill (MD 25/12/2025)Sovereign0.67%
364 Days Tbill (MD 03/10/2025)Sovereign0.45%
91 Days Tbill (MD 04/12/2025)Sovereign0.45%
91 Days Tbill (MD 30/10/2025)Sovereign0.27%
91 Days Tbill (MD 20/11/2025)Sovereign0.22%
91 Days Tbill (MD 28/11/2025)Sovereign0.22%
91 Days Tbill (MD 16/10/2025)Sovereign0.11%
182 Days Tbill (MD 23/10/2025)Sovereign0.09%
91 Days Tbill (MD 23/10/2025)Sovereign0.05%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth - 30 days NAV history

DateNAV
20 October, 202514.648
17 October, 202514.547
16 October, 202514.477
15 October, 202514.396
14 October, 202514.369
13 October, 202514.463
10 October, 202514.450
9 October, 202514.315
8 October, 202514.218
7 October, 202514.262
6 October, 202514.217
3 October, 202514.079
1 October, 202514.100
30 September, 202513.919
29 September, 202513.935
26 September, 202513.888
25 September, 202514.203
24 September, 202514.290
23 September, 202514.359
22 September, 202514.412
19 September, 202514.550
18 September, 202514.547
17 September, 202514.484
16 September, 202514.469
15 September, 202514.432
12 September, 202514.489
11 September, 202514.474
10 September, 202514.437
9 September, 202514.381
8 September, 202514.318

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 14.648 as on 20 October, 2025.
  • What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 4.58% as on 20 October, 2025.
  • What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 10.42% as on 20 October, 2025.